Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Ischemic Heart Disease

  Free Subscription


Articles published in Am J Med

Retrieve available abstracts of 70 articles:
HTML format



Single Articles


    February 2026
  1. SHAMSULDDIN AB
    Preventing stroke or myocardial infarction?: The new monotherapy crossroads in atrial fibrillation and coronary artery disease.
    Am J Med. 2026;139:e63-e64.
    PubMed    


  2. ZHAI L, Teng D
    Beyond one-size-fits-all: The future of beta-blockers in coronary artery disease.
    Am J Med. 2026;139:e57-e58.
    PubMed    


    January 2026
  3. FRISHMAN WH, Aronow WS, Alpert J
    Beta-Adrenergic Blockade in Survivors of Acute Myocardial Infarction: A half-century of Clinical rails and Therapeutic Recommendations.
    Am J Med. 2026 Jan 24:S0002-9343(26)00068-9. doi: 10.1016/j.amjmed.2026.
    PubMed    


  4. WILLETT Y, Yang C, Dunn J, Benson K, et al
    Consumption of Ultra-Processed Foods and Increased Risks of Cardiovascular Disease in U.S. Adults.
    Am J Med. 2026 Jan 24:S0002-9343(26)00054-9. doi: 10.1016/j.amjmed.2026.
    PubMed     Abstract available


  5. MAGEN E, Aamar S, Merzon E, Rahamim E, et al
    Familial Mediterranean Fever and Long-Term Cardiovascular Disease Burden.
    Am J Med. 2026 Jan 9:S0002-9343(26)00020-3. doi: 10.1016/j.amjmed.2026.
    PubMed     Abstract available


    November 2025
  6. SCHADE DS, Blankenship JC, Adolphe A, Philip Eaton R, et al
    Cardiovascular Disease Risk Assessment from Circulating Lipid Particles - A New Challenge for Physicians.
    Am J Med. 2025 Nov 13:S0002-9343(25)00794-6. doi: 10.1016/j.amjmed.2025.
    PubMed    


  7. GU E, Sharninghausen J, Pietz HL, Patel A, et al
    Diphenhydramine overdose in an older adult with neuropsychiatric and cardiovascular comorbidities: a case report.
    Am J Med. 2025 Nov 12:S0002-9343(25)00801-0. doi: 10.1016/j.amjmed.2025.
    PubMed    


  8. REN M, Zhang J, Chi M
    Iron Supplementation May Become a New Option for the Treatment of Cardiovascular Disease.
    Am J Med. 2025;138:e245.
    PubMed    


  9. LIAO Y, Liu S, Lv X
    A Broader Perspective on the Link Between Biological Aging and Cardiovascular Disease in Older Adults With Hypertension.
    Am J Med. 2025;138:e243.
    PubMed    


    October 2025
  10. SCHADE DS, Blankenship JC, Gonzales K, Adolphe A, et al
    A New Paradigm to Reduce Cardiovascular Disease Based on the Pathogenesis of Atherosclerosis.
    Am J Med. 2025 Oct 16:S0002-9343(25)00700-4. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


    September 2025
  11. AHMED M, Rana JS, Ahmed R, Fonarow GC, et al
    Oral anticoagulant monotherapy in patients with chronic coronary disease: An updated meta-analysis.
    Am J Med. 2025 Sep 25:S0002-9343(25)00631-X. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  12. GRINBERG T, Aviv Y, Shiyovich A, Vronsky D, et al
    Coronary Artery Disease Characterization and Plaque Morphology in Patients with Hypertrophic Cardiomyopathy.
    Am J Med. 2025 Sep 25:S0002-9343(25)00619-9. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  13. AJMAL M, Javed A, Corban MT
    Cardiovascular Care in Rural America: Challenges, Insights, and Strategies for Meaningful Improvement.
    Am J Med. 2025 Sep 25:S0002-9343(25)00624-2. doi: 10.1016/j.amjmed.2025.
    PubMed    


  14. KANG Y, Zhao Z, Yang Z, Zeng L, et al
    Beta-Blockers and Outcome in Patients with Suspected Coronary Artery Disease Evaluated Noninvasively.
    Am J Med. 2025;138:1257-1263.
    PubMed     Abstract available


  15. KADOSH S, Balkin N, Carasso S, Amsalem I, et al
    Reduced Left Ventricular Apical Rotation: A Novel Pathophysiological Correlate Underlining Acute Ischemic Mitral Regurgitation.
    Am J Med. 2025;138:1278-1284.
    PubMed     Abstract available


  16. JOLOBE OMP
    The Association of Spontaneous Coronary Artery Dissection and Myocardial Bridging.
    Am J Med. 2025;138:e191.
    PubMed    


    August 2025
  17. LONNBERG F, Siddiqui AJ
    Risk of Cardiovascular Events in Patients Diagnosed with Venous Thromboembolism.
    Am J Med. 2025 Aug 29:S0002-9343(25)00560-1. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  18. BABAR A
    Urgent Call for Targeted Interventions in Cardiovascular-Kidney-Metabolic Syndrome.
    Am J Med. 2025;138:e162.
    PubMed    


    July 2025
  19. AJMAL M, Javed B, Kubba S, Singh K, et al
    Contemporary Review of Myocardial Bridging for Internists.
    Am J Med. 2025;138:1068-1073.
    PubMed     Abstract available


    June 2025
  20. ALKHALFAN F, Hariri E, Aggarwal A, Burton R, et al
    Impact of Atherosclerotic Conditions and Cardiovascular Medications on Abdominal Aortic Aneurysm Growth.
    Am J Med. 2025 Jun 25:S0002-9343(25)00408-5. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  21. NHAT H, Ibrahim R, Mouhaffel R, Abdelnabi M, et al
    SGLT2 Inhibitors and Cardiovascular Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Retrospective Cohort Study.
    Am J Med. 2025 Jun 24:S0002-9343(25)00410-3. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  22. JIANG Y, Zhang H, Zhang C, Geng Y, et al
    Impact of dual antiplatelet therapy duration on long-term outcomes following chronic total occlusion percutaneous coronary intervention.
    Am J Med. 2025 Jun 6:S0002-9343(25)00348-1. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


    May 2025
  23. FROOM P, Lellouche J, Shimoni Z
    TROPONIN TESTS IN PATIENTS ADMITTED TO INTERNAL MEDICINE DEPARTMENTS WITHOUT AN ACUTE CORONARY SYNDROME- LESS IS MORE.
    Am J Med. 2025 May 20:S0002-9343(25)00305-5. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  24. OLA O, Knott JD, De Michieli L, Lobo R, et al
    Lack of Change in the Incidence of Unstable Angina after Transition to High-Sensitivity Cardiac Troponin T.
    Am J Med. 2025 May 18:S0002-9343(25)00304-3. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  25. KU L, Yan Q, Deng W, Ma X, et al
    Right Coronary Artery Ulcerated Atheromatous Plaque.
    Am J Med. 2025 May 18:S0002-9343(25)00240-2. doi: 10.1016/j.amjmed.2025.
    PubMed    


  26. TODUA I, Salem DN
    Cardioesophageal Reflex. Should It Trigger Clinician's Response?
    Am J Med. 2025;138:778-781.
    PubMed     Abstract available


    April 2025
  27. POLLMANN DL, Knott JD, Carvalho PEP, Apple FS, et al
    Cardiac biomarkers for the prediction, discrimination, and risk-stratification of type 2 myocardial infarction: a critical appraisal.
    Am J Med. 2025 Apr 26:S0002-9343(25)00239-6. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  28. GELFMAN DM
    Colchicine in Coronary Artery Disease. When to Use?
    Am J Med. 2025 Apr 15:S0002-9343(25)00230-X. doi: 10.1016/j.amjmed.2025.
    PubMed    


    March 2025
  29. RULI TM JR, Szarvas D, D'Amico A, Leesar M, et al
    A Case of Thyrotoxicosis-Induced Prinzmetal Angina Mimicking Acute ST-Elevation Myocardial Infarction.
    Am J Med. 2025 Mar 28:S0002-9343(25)00199-8. doi: 10.1016/j.amjmed.2025.
    PubMed    


  30. MASINI G, Barsacchi M, Chiusolo S, Alberti M, et al
    Iron Deficiency in Acute Coronary Syndromes - Clinical Correlates and Outcomes.
    Am J Med. 2025 Mar 20:S0002-9343(25)00154-8. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  31. LI L, A G, Guo Y, Liu H, et al
    Early beta-Blocker Use and Clinical Outcomes in Acute Myocardial Injury: A Retrospective Cohort Study.
    Am J Med. 2025 Mar 6:S0002-9343(25)00140-8. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


    February 2025
  32. JIN IT, Lee Y, Choi EY, Lee SH, et al
    Aspirin and clinical outcomes in individuals with incidentally diagnosed coronary artery stenosis.
    Am J Med. 2025 Feb 17:S0002-9343(25)00094-4. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  33. LI X, Huo Y, Diao X, Liu Y, et al
    Prevalence and clinical significance of low QRS voltages in patients presenting for cardiovascular or related diseases.
    Am J Med. 2025 Feb 10:S0002-9343(25)00062-2. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  34. KIM JE, Joo J, Kuku KO, Downie C, et al
    Prevalence, Disparities, and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in US Adults, 2011-2018.
    Am J Med. 2025 Feb 3:S0002-9343(25)00063-4. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


    January 2025
  35. LIPPI G, Sanchis-Gomar F, Lavie CJ
    The recent (2018-2022) US monthly mortality for acute myocardial infarction still peaks in December and January.
    Am J Med. 2025 Jan 18:S0002-9343(25)00035-X. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  36. ALPERT JS
    Perioperative Cardiovascular Management for Patients Undergoing Noncardiac Surgery: Guideline Updated.
    Am J Med. 2025 Jan 16:S0002-9343(24)00832-5. doi: 10.1016/j.amjmed.2024.
    PubMed    


    December 2024
  37. MOVAHED MR, Irannejad K, Venard E, Keating L, et al
    Women with breast implants have higher adjusted abnormal cardiac testing and coronary angiography but lower coronary intervention.
    Am J Med. 2024 Dec 31:S0002-9343(24)00845-3. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  38. SIEGEL J
    Aspirin guided by coronary artery calcium scoring for primary cardiovascular prevention in persons with subclinical coronary atherosclerosis.
    Am J Med. 2024 Dec 12:S0002-9343(24)00798-8. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  39. YANG H, Luo L, Huang Z, Song Y, et al
    Association Between Patient and System Delays and In-Hospital Mortality in Primary PCI for STEMI: Findings from a Large, Nationwide Inpatients Sample.
    Am J Med. 2024;137:1227-1235.
    PubMed     Abstract available


    November 2024
  40. ABUGROUN A, Shah SJ, Fitzmaurice G, Hubbard C, et al
    The Association Between Accelerated Biological Aging and Cardiovascular Outcomes in Older Adults with Hypertension.
    Am J Med. 2024 Nov 12:S0002-9343(24)00702-2. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  41. JEHLE DVK, Sunesra R, Uddin H, Paul KK, et al
    Benefits of Tadalafil and Sildenafil on Mortality, Cardiovascular Disease, and Dementia.
    Am J Med. 2024 Nov 10:S0002-9343(24)00705-8. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  42. YAO Z, Gue Y, Lip GYH
    Comparison of Direct Oral Anticoagulants and Vitamin K Antagonists for Left Ventricular Thrombus: A Global Retrospective Study.
    Am J Med. 2024 Nov 8:S0002-9343(24)00703-4. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  43. DRAVES J, Tekiner H, Yale SH, Yale ES, et al
    Cardiovascular Physical Examination in Internal Medicine Residents: Pause for Concern.
    Am J Med. 2024;137:e213-e214.
    PubMed    


    October 2024
  44. FATUROS A, Wong M, Ghasemiesfe A, Amsterdam EA, et al
    SOCIODEMOGRAPHIC DISPARITIES IN CORONARY ARTERY CALCIUM SCREENING.
    Am J Med. 2024 Oct 16:S0002-9343(24)00643-0. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  45. ABUHASIRA R, Burrack N, Turjeman A, Patt YS, et al
    Comparative Analysis of First-Line Antihypertensive Treatment Classes.
    Am J Med. 2024 Oct 16:S0002-9343(24)00645-4. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  46. DE ALENCAR JN
    Data Concerns in Myocardial Infarction with Right Bundle Branch Block Study: A Closer Look at Methodological Issues.
    Am J Med. 2024;137:e197.
    PubMed    


  47. GUIMARAES PO, Lopes RD, Wojdyla DM, Alexander JH, et al
    Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial.
    Am J Med. 2024;137:958-965.
    PubMed     Abstract available


    September 2024
  48. TSAI MH, Chen YY, Liou HH, Wang JT, et al
    Febuxostat leads to better cardiovascular outcomes compared to allopurinol in patients with advanced chronic kidney disease: A Population-based Cohort Study.
    Am J Med. 2024 Sep 26:S0002-9343(24)00622-3. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  49. KIM YJ, Malhi J, Trost J, Leucker T, et al
    A Case-Based Approach to the Management of Patients with Chronic Coronary Disease: Updates from the 2023 AHA/ACC Guidelines.
    Am J Med. 2024 Sep 14:S0002-9343(24)00576-X. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  50. JORDA A, Pecho T, Horvath LC, Nishani E, et al
    Association of electrocardiogram findings with clinical outcomes in patients with chronic coronary syndrome: an analysis of the ISCHEMIA trials.
    Am J Med. 2024 Sep 14:S0002-9343(24)00572-2. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


    August 2024
  51. MADIAS JE
    Blood pressure/Heart Rate-Derived Ratios, as Indices of Health and Cardiovascular Pathology.
    Am J Med. 2024 Aug 10:S0002-9343(24)00492-3. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  52. KIM J, Kang D, Park H, Park TK, et al
    Angiotensin receptor blockers versus angiotensin converting enzyme inhibitors in acute myocardial infarction without heart failure.
    Am J Med. 2024 Aug 3:S0002-9343(24)00477-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  53. PALATNIC L, Kim JA, Kim SY, Moras E, et al
    Human Papillomavirus as Non-Traditional Cardiovascular Risk Factors: Fact or Fiction? Part 2.
    Am J Med. 2024 Aug 3:S0002-9343(24)00481-9. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  54. LYAS C
    The Beneficial Effects of Fruits and Vegetables on Kidney Disease Progression and Cardiovascular Disease Risk.
    Am J Med. 2024 Aug 2:S0002-9343(24)00486-8. doi: 10.1016/j.amjmed.2024.
    PubMed    


  55. GARCIA-VEGA D, Cinza-Sanjurjo S, Eiras S, Gonzalez-Juanatey JR, et al
    Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry.
    Am J Med. 2024;137:761-769.
    PubMed     Abstract available


  56. HONG B, Bea S, You SC, Chang Y, et al
    Comparative Effectiveness and Safety of Ticagrelor and Clopidogrel in Patients With or Without Chronic Liver Disease: A Nationwide Cohort Study.
    Am J Med. 2024;137:742-750.
    PubMed     Abstract available


  57. SHAH KS, Makaryus AN
    Navigating Diversity: Optimizing Data Collection for Cardiovascular Health.
    Am J Med. 2024 Aug 1:S0002-9343(24)00482-0. doi: 10.1016/j.amjmed.2024.
    PubMed    


    July 2024
  58. EJIRI K, Mok Y, Ding N, Chang PP, et al
    Chest symptoms and long-term risk of incident cardiovascular disease.
    Am J Med. 2024 Jul 30:S0002-9343(24)00474-1. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  59. GORAYA N, Madias NE, Simoni J, Kahlon M, et al
    Kidney and Cardiovascular Protection Using Dietary Acid Reduction in Primary Hypertension: A Five-Year, Interventional, Randomized, Control Trial.
    Am J Med. 2024 Jul 8:S0002-9343(24)00357-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  60. ARSHAD F
    Breaking Barriers: Enhancing Statins Utilization for Cardiovascular Protection in MAFLD.
    Am J Med. 2024;137:e142.
    PubMed    


    June 2024
  61. PALATNIC L, Kim JA, Kim SY, Moras E, et al
    Human Papillomavirus as Non-Traditional Cardiovascular Risk Factors: Fact or Fiction? Part 1.
    Am J Med. 2024 Jun 24:S0002-9343(24)00397-8. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


    May 2024
  62. LANG K, Chew C, De La Rosa M, Bertram AK, et al
    Performance of Cardiovascular Physical Exam Skills by Internal Medicine Residents.
    Am J Med. 2024 May 11:S0002-9343(24)00269-9. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  63. SMATI H, Sellke FW, Bourque JM, Qadeer YK, et al
    Coronary Microvascular Dysfunction: A Guide for Clinicians.
    Am J Med. 2024 May 7:S0002-9343(24)00282-1. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  64. KAWADA T
    Depression, Cardiovascular Disease, and Mortality.
    Am J Med. 2024;137:e96.
    PubMed    


    April 2024
  65. SORENSEN NA, Fakhri Y, Gossling A, Neumann JT, et al
    Impact of quantitative ST-T analysis in patients with suspected myocardial infarction presenting with right bundle branch block.
    Am J Med. 2024 Apr 24:S0002-9343(24)00244-4. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  66. VELASQUEZ GARCIA HA, Wong S, Jeong D, Binka M, et al
    Risk of major adverse cardiovascular events after SARS-CoV-2 infection in British Columbia: a population-based study.
    Am J Med. 2024 Apr 24:S0002-9343(24)00237-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


    March 2024
  67. HOWICK V JF, Saric P, Elwazir M, Newman DB, et al
    A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19.
    Am J Med. 2024 Mar 26:S0002-9343(24)00162-1. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  68. ROOS A, Edgren G
    High-Sensitivity Cardiac Troponins in Patients with Chest Pain and Treatment With Oral Antineoplastic Agents Associated With Cardiovascular Toxicity.
    Am J Med. 2024 Mar 13:S0002-9343(24)00143-8. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  69. FREUND O, Shetrit A, Bar-Shai A, Zornitzki L, et al
    Smoking and respiratory diseases in patients with coronary microvascular dysfunction.
    Am J Med. 2024 Mar 12:S0002-9343(24)00134-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


    February 2024
  70. HAMMOND MM, Cameron NA, Shah NS, Khan SS, et al
    An Age-Period-Cohort Analysis of Cardiovascular Disease Mortality in the United States from 1999 to 2018.
    Am J Med. 2024 Feb 22:S0002-9343(24)00108-6. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.